Gardiner Healthcare Acquisitions Overview
Valuation check: GDNR's ROE is -5.22%, above the sector sector average of -5.84%.
Get informed when a big investor buys or sells
+ Follow-5.22%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for GDNR is -5.22%. That is above the sector sector average of -5.84%. Investors often review this figure alongside Gardiner Healthcare Acquisitions's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, GDNR currently prints -5.22% for ROE, while the sector average sits near -5.84%. That is roughly 10.7% above the sector mean. Large gaps often invite a closer look at Gardiner Healthcare Acquisitions's growth, margins, and balance sheet.
Return on Equity shows how effectively Gardiner Healthcare Acquisitions converts resources into returns. At -5.22%, GDNR may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting GDNR's ROE (-5.22%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
